These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16141455)

  • 1. Classification of cancer cell lines using an automated two-dimensional liquid mapping method with hierarchical clustering techniques.
    Wang Y; Wu R; Cho KR; Shedden KA; Barder TJ; Lubman DM
    Mol Cell Proteomics; 2006 Jan; 5(1):43-52. PubMed ID: 16141455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive proteome analysis of ovarian cancers using liquid phase separation, mass mapping and tandem mass spectrometry: a strategy for identification of candidate cancer biomarkers.
    Wang H; Kachman MT; Schwartz DR; Cho KR; Lubman DM
    Proteomics; 2004 Aug; 4(8):2476-95. PubMed ID: 15274142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Classifications of ovarian cancer tissues by proteomic patterns.
    Zhu Y; Wu R; Sangha N; Yoo C; Cho KR; Shedden KA; Katabuchi H; Lubman DM
    Proteomics; 2006 Nov; 6(21):5846-56. PubMed ID: 17068758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 2-D liquid separations/mass mapping method for interlysate comparison of ovarian cancers.
    Kachman MT; Wang H; Schwartz DR; Cho KR; Lubman DM
    Anal Chem; 2002 Apr; 74(8):1779-91. PubMed ID: 11985308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A protein molecular weight map of ES2 clear cell ovarian carcinoma cells using a two-dimensional liquid separations/mass mapping technique.
    Wang H; Kachman MT; Schwartz DR; Cho KR; Lubman DM
    Electrophoresis; 2002 Sep; 23(18):3168-81. PubMed ID: 12298089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic analyses of serous and endometrioid epithelial ovarian cancers - cases studies - molecular insights of a possible histological etiology of serous ovarian cancer.
    Longuespée R; Gagnon H; Boyon C; Strupat K; Dauly C; Kerdraon O; Ighodaro A; Desmons A; Dupuis J; Wisztorski M; Vinatier D; Fournier I; Day R; Salzet M
    Proteomics Clin Appl; 2013 Jun; 7(5-6):337-54. PubMed ID: 23589350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histological classification of ovarian cancer.
    Kaku T; Ogawa S; Kawano Y; Ohishi Y; Kobayashi H; Hirakawa T; Nakano H
    Med Electron Microsc; 2003 Mar; 36(1):9-17. PubMed ID: 12658347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the molecular differences between ovarian endometrioid carcinoma and ovarian serous carcinoma.
    Madore J; Ren F; Filali-Mouhim A; Sanchez L; Köbel M; Tonin PN; Huntsman D; Provencher DM; Mes-Masson AM
    J Pathol; 2010 Feb; 220(3):392-400. PubMed ID: 19967725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis.
    McCluggage WG
    Pathology; 2011 Aug; 43(5):420-32. PubMed ID: 21716157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isoelectric focusing nonporous RP HPLC: a two-dimensional liquid-phase separation method for mapping of cellular proteins with identification using MALDI-TOF mass spectrometry.
    Wall DB; Kachman MT; Gong S; Hinderer R; Parus S; Misek DE; Hanash SM; Lubman DM
    Anal Chem; 2000 Mar; 72(6):1099-111. PubMed ID: 10740846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A two-dimensional liquid-phase separation method coupled with mass spectrometry for proteomic studies of breast cancer and biomarker identification.
    Hamler RL; Zhu K; Buchanan NS; Kreunin P; Kachman MT; Miller FR; Lubman DM
    Proteomics; 2004 Mar; 4(3):562-77. PubMed ID: 14997480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isoelectric focusing nonporous silica reversed-phase high-performance liquid chromatography/electrospray ionization time-of-flight mass spectrometry: a three-dimensional liquid-phase protein separation method as applied to the human erythroleukemia cell-line.
    Wall DB; Kachman MT; Gong SS; Parus SJ; Long MW; Lubman DM
    Rapid Commun Mass Spectrom; 2001; 15(18):1649-61. PubMed ID: 11555863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential diagnosis of mesothelial and ovarian cancer cells in ascites by immunocytochemistry using Ber-EP4 and calretinin.
    Sato S; Okamoto S; Ito K; Konno R; Yajima A
    Acta Cytol; 2000; 44(3):485-8. PubMed ID: 10834020
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunohistochemical detection of ras p21 oncoprotein in undifferentiated and well-differentiated epithelial carcinomas of the human ovary.
    Kuwashima Y; Shisa H; Uehara T; Kurosumi M; Kobayashi Y; Tanuma J; Shiromizu K; Matsuzawa M; Kishi K
    Anticancer Res; 1995; 15(6B):2847-50. PubMed ID: 8669877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGFR and steroid receptors in ovarian carcinoma: comparison with prognostic parameters and outcome of patients.
    Fischer-Colbrie J; Witt A; Heinzl H; Speiser P; Czerwenka K; Sevelda P; Zeillinger R
    Anticancer Res; 1997; 17(1B):613-9. PubMed ID: 9066588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of extracellular matrix metalloproteinase inducer and matrix metalloproteinase 2 in epithelial ovarian cancer.
    Sillanpää S; Anttila M; Suhonen K; Hämäläinen K; Turpeenniemi-Hujanen T; Puistola U; Tammi M; Sironen R; Saarikoski S; Kosma VM
    Tumour Biol; 2007; 28(5):280-9. PubMed ID: 17962725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of survivin is associated with malignant potential in epithelial ovarian carcinoma.
    Takai N; Miyazaki T; Nishida M; Nasu K; Miyakawa I
    Int J Mol Med; 2002 Aug; 10(2):211-6. PubMed ID: 12119561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Alterations of TP53 are a Defining Feature of Ovarian High-Grade Serous Carcinoma: A Rereview of Cases Lacking TP53 Mutations in The Cancer Genome Atlas Ovarian Study.
    Vang R; Levine DA; Soslow RA; Zaloudek C; Shih IeM; Kurman RJ
    Int J Gynecol Pathol; 2016 Jan; 35(1):48-55. PubMed ID: 26166714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-Stage High-Grade Serous Ovarian Carcinomas: Support for an Extraovarian Origin.
    Morency E; Leitao MM; Soslow RA
    Int J Gynecol Pathol; 2016 May; 35(3):222-9. PubMed ID: 26630225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. My approach to and thoughts on the typing of ovarian carcinomas.
    McCluggage WG
    J Clin Pathol; 2008 Feb; 61(2):152-63. PubMed ID: 17704261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.